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ABSTRACT 
 
 Diabetes mellitus (DM) induces bone deterioration, while mechanical stimulation 
promotes osteocyte-driven bone formation. We aimed to evaluate the interaction of acute 
exposure (24h) to high glucose (HG) with both the pro-survival effect conferred to osteocytic 
MLO-Y4 cells and osteoblastic MC3T3-E1 cells by mechanical stimulation and the interaction 
of these cells with osteoclast precursor RAW264.7 cells. We found that 24h of HG (25 mM) 
pre-exposure prevented both cell survival and ERK and β-catenin nuclear translocation upon 
mechanical stimulation by fluid flow (FF) (10 min) in both MLO-Y4 and MC3T3-E1 cells. 
However, migration of RAW 264.7 cells was inhibited by MLO-Y4 cell-conditioned medium 
(CM), but not by MC3T3-E1 cell-CM, with HG or FF. This inhibitory effect was associated 
with consistent changes in VEGF, RANTES, MIP-1α, MIP-1β MCP-1 and GM-CSF in MLO-
Y4 cell-CM. RAW264.7 proliferation was inhibited by MLO-Y4 CM under static or HG 
conditions, but itincreased by FF-CM with or without HG. In addition, both FF and HG 
abrogated the capacity of RAW 264.7 cells to differentiate into osteoclasts, but in a different 
manner. Thus, HG-CM in static condition allowed formation of osteoclast-like cells, which 
were unable to resorb hydroxyapatite. In contrast, FF-CM prevented osteoclastogenesis even in 
HG condition. Moreover, HG did not affect basal RANKL or IL-6 secretion or their inhibition 
induced by FF in MLO-Y4 cells. In conclusion, this in vitro study demonstrates that HG exerts 
disparate effects on osteocyte mechanotransduction, and provides a novel mechanism by which 
DM disturbs skeletal metabolism through altered osteocyte-osteoclast communication.  
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INTRODUCTION 
Diabetes mellitus (DM) is a complex disease with deleterious effects on the skeleton. In 
fact, both type 1 (T1D) and type 2(T2D) DM are associated with an increased risk of fractures 
(Carnevale et al., 2004; Yamamoto et al., 2009); although their bone phenotypes are different. 
Thus, while T2D patients have normal or high bone mineral density (BMD), T1D patients have 
reduced BMD (Hofbauer et al., 2007; Nicodemus and Folsom, 2001; Vestergaard, 2007). The 
underlying mechanisms of bone tissue deterioration and fracture risk elevation in DM remain 
ill- defined. The increase of glucose concentration and advanced glycation end products (AGEs) 
accumulation present in both types of DM are thought to be responsible for at least some of the 
features of diabetic osteopathy, such as the inhibition of proliferation and differentiation of bone 
cell precursors (Botolin and McCabe, 2006; Saito et al., 2006).  
Mechanical force is one of the most important inputs that the skeleton receives to 
regulate bone mass, shape and microarchitecture (Robling and Turner, 2009). The skeleton is 
able to adapt to an increased load by stimulating bone formation, while skeletal disuse leads to 
an increased bone resorption (Aguirre et al., 2006; Bikle et al., 2003; Burr et al., 2002). It is now 
well established that osteocytes are the main mechanosensor cell in bone, regulating both 
osteoblast and osteoclast function. Osteocytes are long-lived cells, trapped in the bone 
mineralized matrix and exhibiting cytoplasmic processes inside narrow tunnels called canaliculi. 
These cell dendrites define an extensive and complex network, which allows an effective 
communication not only between neighbor osteocytes but also between osteocytes and 
osteoblasts and osteoclasts located on the bone surface. This strategic position in the bone 
mineralized matrix and the complexity of the osteocyte process network allows osteocytes to 
sense changes in bone load, sending signals to osteoblasts and osteoclasts to form or resorb 
bone (Bellido, 2014; Maycas et al, 2016). Osteocytes are able to control osteoblast function by 
producing sclerostin, encoded by the SOST gene, which inhibits osteoblast activity through 
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antagonizing the Wnt/β-catenin pathway (Kamiya et al., 2008; Poole et al., 2005). In addition, 
osteocytes produce the receptor activator of nuclear factor κB ligand (RANKL) that supports 
osteoclast differentiation and activity (Nakashima et al., 2011). Lack of mechanical forces 
induces osteocyte apoptosis, and this event is related to the recruitment and differentiation of 
osteoclast precursors. In the absence of mechanical stimulation, osteocytes also produce 
osteoclast signals to stimulate bone resorption (Aguirre et al., 2006; Plotkin et al., 2015). 
Factors involved in angiogenesis and osteoclast function, such as vascular endothelial growth 
factor (VEGF) and RANKL, respectively, are known to increase in live osteocytes located close 
to apoptotic osteocytes, but the underlying mechanisms targeting bone resorption at specific 
bone sites are still ill-defined (Kennedy et al., 2012).Chemokines are a family of cytokines that 
provide key signals for recruiting different subpopulations of leukocytes and other cell types in 
both physiological and pathological situations (Bryant et al, 2015). Some chemokines are 
expressed by bone cells and could be involved in osteoclast recruitment (Lin et al, 2014; Yu et 
al, 2004). 
 
Of interest, it has been recently shown that a diabetic environment hampers some 
downstream responses to mechanical stimulation both in vivo and in vitro (Parajuli et al., 2015). 
Therefore, in the present study, we hypothesized that a high glucose (HG) environment might 
interact with mechanotransduction in MLO-Y4 osteocytes and subsequently with osteoclast 
recruitment, differentiation and activity, using murine RAW 264.7 monocytic cells as osteoclast 
precursors. 
 
MATERIALS AND METHODS 
Cell cultures: The osteocytic MLO-Y4 cell line, derived from murine long bones(Kato 
et al., 1997) and MLO-Y4 nuclear-GFP cells, stably transfected with nuclear green fluorescent 
protein (nGFP) (Plotkin et al., 1999),were grown in α-MEM supplemented with 2.5% fetal 
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bovine serum (FBS), 2.5% calf serum (CS) and 1% penicillin-streptomycin in 5% CO2 at 37 ºC. 
Mouse pre-osteoblastic MC3T3-E1 cells (CRL-2593; American Type Culture Collection, 
Mannasas, VA, USA) were grown in α-MEM supplemented with 10% FBS, 1% penicillin-
streptomycin and 2 mM glutamine in 5% CO2at 37 ºC. Murine RAW 264.7 macrophages 
(Suzuki et al., 2008) were grown in α-MEM supplemented with 10% FBS and 1% penicillin-
streptomycin in 5% CO2 at 37 ºC. Both MLO-Y4 and MC3T3-E1 cells were plated at 2x104 
cells/cm2 on collagen-coated glass slides (FlexCell, Hillsborough, NC, USA); the next day, 
fresh medium with high D-glucose (HG) (the α-MEM medium -containing 5.5 mM of D-
glucose- was supplemented with the necessary amount of D-glucose to reach a final 
concentration of 25 mM,) (or high L-glucose as osmotic  control) or normal glucose  (NG) (5.5 
mM) was added for 24 h.  Then, cells were submitted or not (static control, SC) to mechanical 
stress by laminar fluid flow (FF) with a shear stress of 10 dynes/cm2, 8 Hz, for 10 min in a 
Flexcell® Streamer® shear stress device. The media flowed over the cells was consistently 
serum-depleted α-MEM in every experimental condition. The concentration used for HG (25 
mM) is equivalent to 450 mg/dl a widely used concentration in studies mimicking the diabetic 
milieu in bonecells (Lozano et al, 2009; Parajuli et al, 2015). The magnitude of the predicted 
fluid flow-induced shear stress in physiological conditions in osteocytes is estimated to be in the 
range of 8-30 dynes/cm2. Thus, the regimen used in our study lies within the frame of 
physiological relevance (Sorkin et al, 2004; Weinbaum et al, 1994).  Thereafter, different 
protocols were carried out depending on the endpoint studied. Thus, for Western blot analysis, 
protein extracts were obtained immediately after FF. For apoptosis determination, cells were 
exposed to a pro-apoptotic agent (see below) for an additional 6h.Cells were cultured with fresh 
medium (α-MEM without serum) for an additional 18 h after FF (or SC) to collect the cell-
conditioned medium (CM) in the different experimental groups: CM from SC cells in NG 
medium; CM from FF-stimulated cells in NG medium; CM from SC cells pre-treated with 
either HG or L-glucose-containing medium; CM from FF-stimulated cells pre-cultured in HG 
medium. 
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Apoptosis and cell viability determination: Following FF, MLO-Y4 nuclear-GFP or 
MC3T3-E1 cells were exposed to the well characterized pro-apoptotic agent etoposide (50 µM) 
in FBS-depleted medium for 6 h and subsequently were fixed with neutral buffered formalin. 
Apoptosis was assessed by enumerating nGFP positive MLO-Y4 cells exhibiting chromatin 
condensation and nuclear fragmentation under a fluorescence microscope, as previously 
reported (Plotkin et al., 1999). For MC3T3-E1 cell death determination, non-adherent cells were 
collected and pooled with adherent cells (after gentle trypsinization). Cell death was determined 
by trypan blue exclusion, calculating the percent of nonviable cells -exhibiting intracellular 
staining- per total cell number. 
Western blot analysis: Total cell protein was extracted with 50 mMTris–HCl, pH 7.4, 
150 mMNaCl, 1mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, and 0.1% sodium 
dodecyl sulfate (SDS), supplemented with protease inhibitor cocktail P8340 (Sigma-Aldrich, St. 
Louis, MO, USA) and phosphatase inhibitor cocktail Set II (Calbiochem, San Diego, CA, 
USA). Nuclear protein extracts were obtained by using the “Subcellular protein fractionation 
kit” (Pierce, Rockford, IL, USA), according to the manufacturer’s instructions. Protein content 
was determined by BCA Protein Assay (Thermo Fisher Scientific, Rockford, IL, USA) using 
bovine serum albumin (BSA) as standard. Protein extracts (25-30 μg) were separated on 10 % 
polyacrylamide gels in reducing conditions, followed by transfer to nitrocellulose membranes 
(GE-Amersham, Buckinghamshire, UK). Blots were blocked with 2.5% defatted milk in 0.1% 
Tween-Tris buffered saline (TBS) or with 5% BSA in 0.1% Tween-TBS, pH 7.4, at room 
temperature for 1 h, and then probed overnight at 4ºC with the following rabbit polyclonal 
antibodies: p-GSK3β(Ser9) (Cell Signalling, Beverly, MA, USA) (at 1:500 dilution), β-catenin 
antibody (Abcam, Cambridge, MA, USA) (at 1:4000 dilution), p-ERK1/2 (Thr202/Tyr204) and 
ERK1/2 antibody (Cell Signalling) (each at 1:1000 dilution); and the mouse monoclonal 
antibody GSK3β (Cell Signalling). For loading controls, mouse monoclonal anti-α-tubulin 
antibody (Sigma-Aldrich) and rabbit polyclonal lamin B1 antibody (Abcam) were used where 
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appropriate. After incubation with the corresponding secondary horseradish peroxidase-coupled 
IgG (Santa Cruz Biotechnology), blots were developed with ECL system (GE-Amersham), and 
band intensities were quantified by densitometry. 
Cytokine determination: Thechemokinesgranulocyte macrophage colony-stimulated factor 
(GM-CSF), monocyte chemotactic protein (MCP)-1, macrophage inflammatory protein (MIP)-
1α, MIP-1β, regulated on activation, normal T cell expressed and secreted (RANTES), and 
VEGF, were evaluated in MLO-Y4 cell-CM using the Milliplex system (Merck Millipore, St. 
Charles, MO, USA) on the Bio-Plex platform (Bio-Rad Laboratories, Hercules, CA, USA). 
RANKL and IL-6 were evaluated in MLO-Y4 cell-CM using specific mouse ELISA Kits from 
Abcam and Gen-Probe (Diaclone, Besancon, France), respectively, according to the 
corresponding manufacturer’s instructions. The sensitivity of the assays was 10.9 pg/ml for 
GM-CSF, 6.7 pg/ml for MCP-1, 7.7 pg/ml for MIP-1α, 11.9 pg/ml forMIP-1β, 2.7 pg/ml for 
RANTES, 0.3 pg/ml for VEGF, 4 pg/ml for RANKL and 10 pg/ml for IL-6 and their inter assay 
variation coefficient was <12 %. 
Transwell migration assay: Migration assay was performed using Costar transwell cell 
culture chamber inserts (Corning Costar Corporation, Cambridge, MA) with an 8 μm pore size. 
Briefly, 5 × 104 RAW 264.7 cells were placed in the upper chamber in 100 μL of serum-
freestandard medium containing 20% of each MLO-Y4 (A) or MC3T3-E1 (B) cell-conditioned 
medium for 6 h. Then, the medium and the upper cell layer were removed with the aid of a 
cotton swab, and cells on the underside of the transwell were fixed, stained with crystal violet 
and counted in five randomly selected fields at 200× magnification using the phase contrast 
microscope. 
Wound healing assay: RAW 264.7 cells (5 × 104 /cm2) were seeded on 6-well plates in 
α-MEM supplemented with 10% FBS. The day after, a scratch was made across the RAW 264.7 
cell layer using a sterile pipette tip. Cells were then washed with phosphate-buffered saline 
(PBS) and the medium was replaced by serum-free standard medium containing 20% of each 
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MLO-Y4 cell-CM for 6 h. Cells were thereafter cultured for 8 h to allow cell migration, and 
migrated cells into the scratch were counted at 200x magnification using a Leica DM6000 phase 
contrast microscope. 
Osteoclast differentiation on hydroxyapatite disks: RAW-264.7 cells were seeded on 
hydroxyapatite disks, prepared as previously described (Matesanz et al., 2014), placed into each 
well of a 24-well culture plate, at a density of 1x104 cells/cm2 in α-MEM without phenol red and 
supplemented with 4% FBS. In order to stimulate osteoclast differentiation, 40 ng/ml of mouse 
RANKL and 25 ng/ml M-CSF were added to the culture medium and cells were cultured for 14 
days in the presence of MLO-Y4 cell-CM (20% in standard medium), renewing culture medium 
every 3 days, as previously reported (Torres-Rodríguez et al., 2016). Subsequently, cells were 
washed with PBS, harvested using PBS-EDTA for 10 min, and counted in a Neubauer 
hemocytometer for evaluating cell proliferation. Cell suspensions were then centrifuged at 310g 
for 10 min and resuspended in fresh medium for the analysis of cell viability. Cell viability was 
determined by propidium iodide (PI) exclusion and flow cytometry after addition of PI (0.005% 
in PBS, Sigma-Aldrich) to stain the DNA of dead cells.  
Morphological studies by confocal microscopy: RAW 264.7 cells grown on 
hydroxyapatite disks as described above for 14 d were fixed with 3.7% p-formaldehyde in PBS 
for 10 min, washed with PBS and permeabilized with 0.1% Triton X-100 for 3-5 min. The disks 
with permeabilized cells were then washed with PBS and pre-incubated with 1% BSA in PBS 
for 20-30 min. Thereafter, cells were incubated with rhodamine phalloidin (1:40, v/v, Molecular 
Probes, Eugene, OR, USA) for 20 min to stain F-actin filaments. Samples were then washed 
with PBS and the cell nuclei were stained with DAPI (4′-6-diamidino-2′-phenylindole; 
Molecular Probes) at 3 µM in PBS. After staining and washing with PBS, cells were examined 
using a Leica SP2 confocal laser scanning microscope. Rhodamine fluorescence was excited at 
540 nm and measured at 565 nm. DAPI fluorescence was excited at 405 nm and measured at 
420–480 nm. The presence of multinucleated cells with F-actin rings was used as indicative of 
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osteoclast-like cell differentiation. To evaluate the geometry of resorption cavities produced by 
osteoclast-like cells on the surface of hydroxyapatite disks, cells were detached after 14 d of 
culture as described above, and subsequently, disks were dehydrated, coated with gold-
palladium and examined with a JEOL JSM-6400 scanning electron microscope. 
Statistics: Data are expressed as mean ± standard deviation (SD) of at least 3 
experiments carried out in triplicate. Statistical analysis was performed using GraphPad Prism 
(GraphPad software, La Jolla, CA, USA). Data were analyzed by Kruskal-Wallis test followed 
byDunn’s test. p<0.05 was considered significant.  
RESULTS 
It has been previously demonstrated that the same FF regime used here (10 dynes/cm2; 
10 min) exerted a pro-survival effect onosteocyticMLO-Y4 cells, related to β-catenin 
stabilization and a nuclear ERK translocation (de Castro et al., 2015; Gortázar et al., 2013; 
Maycas et al., 2015). In the present study, we found that FF induced an increase in p-GSK3β, 
promoting the stabilization and nuclear increase of β-catenin (Fig 1A); and also induced ERK 
phosphorylation (p-ERK) and its translocation to the nucleus (Fig 1B). Pre-exposure of MLO-
Y4 cells to HG (25 mM) for 24 h inhibited both β-catenin and ERK nuclear translocation 
induced by FF; although HG did not alter the phosphorylation and subcellular localization of the 
proteins in SC conditions (Fig. 1A,B). Moreover, we found that this HG exposure –but not L-
glucose as osmotic control- of MLO-Y4 cells increased apoptosis induced by etoposide, and 
reversed the protection induced by FF (Fig. 1C, left). Of note, the difference in osteocyte 
apoptosis between HG and NG was higher in FF than in SC condition (Fig. 1C, right).Similar 
findings with respect to protein phosphorylation andsubcellular localization, as well as cell 
death, were observed in pre-osteoblastic MC3T3-E1 cells (Fig. 2). 
We next analyzed the effect of HG and FF on the ability of both cell lines to interact 
with osteoclast precursors. For this purpose, MLO-Y4 and MC3T3-E1 cells were pre-exposed 
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to either HG or normal glucose (NG) for 24 h, and cells were then subjected to FF or not (SC), 
followed by collecting the corresponding CM at 18h. We found that the CM from MLO-Y4 
cells pre-exposed to HG inhibited RAW 264.7 cell migration (Fig. 3A, left). This inhibition was 
of the same magnitude as that induced by the CM from FF-stimulated MLO-Y4 cells, 
independently of pre-exposure or not to HG (Fig. 3A, left). Similar results were obtained when 
RAW 264.7 cell migration was assessed using the wound healing assay (Fig. 3A, right). In 
contrast, MC3T3-E1-cell CMs from any of these experimental conditions failed to significantly 
affect RAW 264.7 cell migration (Fig. 3B).The impact of HG and FF on the secretion of several 
chemokines by MLO-Y4 cells was next evaluated. Consistent with the aforementioned 
migration data, both FF and HG were found to inhibit the secreted levels of VEGF, RANTES, 
MIP-1a, MIP-1b, MCP-1 and GM-CSF (Fig. 4). Of note, HG in fact potentiated the inhibitory 
effect of FF on the secretion of all these chemokines (Fig. 4).   
We next assessed the effect of the different MLO-Y4 cell-CMs on the viability, 
proliferation and differentiation of osteoclast precursors after 14 d in osteoclast differentiation 
medium. First, we observed that none of these CMs tested significantly modified RAW 264.7 
cell viability (Fig. 5A). On the other hand, the CM from SC cells pre-treated or not with HG (or 
L-glucose) inhibited RAW 264.7 cell proliferation; whereas the CM from MLO-Y4 cells 
subjected to FF highly stimulated proliferation, independently of HG pre-exposure or not (Fig. 
5B). The effect of MLO-Y4 cell-CM on osteoclastogenesis was also analyzed in RAW 264.7 
cells after 14 days of culture in the presence of RANKL and M-CSF by the identification of 
actin rings as a critical feature of mature osteoclasts. The CM from NG-SC osteocytic cells was 
able to induce osteoclast differentiation, inducing the formation of giant cells with actin rings 
and at least 3 nuclei, as observed by confocal microscopy (Fig.5C, upper panel).To evaluate 
the activity of these osteoclast-like cells, we seeded RAW 264.7 cells on hydroxyapatite disks 
for 14 d in the presence of RANKL/M-CSF and the different MLO-Y4 cell-CMs.CM from cells 
in SC conditions induced osteoclast activity, as detected by the geometry of resorption cavities 
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produced by these cells whenexamined by SEM (Fig. 5C, lower panel, D). Interestingly, CM 
from MLO-Y4 cells pre-treated with HG allowed osteoclast-like cell formation but these cells 
showed minimal resorption activity on hydroxyapatite; whereas CM from FF-stimulated cells 
decreased osteoclast activity, even in the absence of HG (Fig. 5C, D). 
Consistent with these findings, RANKL and IL-6 secretion by MLO-Y4 cells were not 
affected by cell exposure to either HG (or L-glucose) in SC conditions; whereas FF stimulation, 
following HG pre-exposure or not, decreased the secreted levels of both cytokines (Fig. 6).  
 
DISCUSSION 
DM is a metabolic disease characterized by an inappropriate regulation of glucose 
metabolism affecting a variety of tissues including bone. At the cellular level, HG has been 
described to: inhibit proliferation and osteogenic differentiation of bone marrow mesenchymal 
cells; impair osteoblast mineralization; increase osteocyte and osteoblast apoptosis; and inhibit 
RANKL-induced osteoclastogenesis (Bouillon et al., 1995; Wittrant et al., 2008; Xu et al., 
2015). In the present study, we further confirmed that HG prevented the protection conferred by 
mechanical stimulation by FF to osteoblastic lineage cells. Furthermore, we disclosed a 
differential impact of FF and HG on osteocyte-osteoclast communication. 
Both osteoblasts and osteocytes are able to detect and respond to mechanical and 
hormonal stimuli, but osteocytes -the main cell type in bone- uniquely coordinate the function 
of both osteoblasts and osteoclasts. Whereas mechanical loading was found to promote both 
osteoblast and osteocyte survival (present results and Bin et al, 2016; Maycas et al, 2016),only 
dying osteocytes (not osteoblasts) induce osteoclastogenesis (Kogianni et al, 2008).In this study, 
we aimed to explore the putative effect of HG on osteocyte-osteoclast communication, and we 
also used an osteoblastic cell line, MC3T3-E1 cells, to confirm the specificity of the observed 
effects of the CM from osteocytic MLO-Y4 cells on the migration of osteoclast precursors. As 
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shown in fig 3, as expected, only the CM from osteocytic MLO-Y4 but not that from 
osteoblastic MC3T3-E1 cells modulated osteoclast precursor migration, confirming the 
important role of osteocytes in osteoclast function. 
A very recent study has shown that the anabolic effect induced by bone loading  was 
impaired in a T1D mouse model (Parajuli et al., 2015). These authors also showed that some of 
the beneficial effects induced by FF in MLO-Y4 cells, namely the inhibition of caspase 3/7 
expression and induction of prostaglandin E2, were compromised by HG exposure. In the same 
line, we here found that cell survival, and two related mechanistic events -β-catenin and ERK 
nuclear translocation- induced by mechanical stimulation in MLO-Y4 cells were dramatically 
decreased by HG exposure. In the aforementioned study, HG exposure was also found to 
reverse the reduction of RANKL secretion induced by FF, in contrast to the present data. This 
difference between the two studies could be explained by the different pattern of treatments: 
whereas we exposed MLO-Y4 cells to HG for 24 h followed by 10 min FF, in the report by 
Parajuli et al.(2015), MLO-Y4 cells were incubated with HG for 72 h prior to FF for 2 h. 
Indeed, the impact of HG on osteoblastic cells depends on time of exposure (Botolin et al, 2006; 
López-Herradón et al, 2013). In the present study, we observed that an acute exposure of MLO-
Y4 cells to HG (24 h) prevented both ERK and β-catenin relocalization but only after 
mechanical stimulation by FF and not under SC conditions. Thus, this time of HG exposure 
does not seem to be sufficient to affect the basal levels of both proteins, although it might affect 
the formation of other components of the signalsome triggered by mechanotransduction leading 
to ERK and beta-catenin relocalization (Plotkin et al, 2005; Gortázar et al., 2013). In this regard,  
α5-integrin, which is required for osteocyte mechanotransduction (Plotkin et al, 2005), has 
recently been shown to be reduced by HG in fibroblastic cells (Almeida et al, 2016). 
In the present study, the secretion of various chemokines, namely VEGF, RANTES, 
MIP-1α, MIP-1β, MCP-1 and GM-CSF, was found to be inhibited following mechanical 
stimulation of MLO-Y4 cells by FF. This inhibitory effect was recapitulated -or even 
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potentiated- by HG pre-exposure of these cells. Accordingly, RAW 264.7 cell migration in the 
presence of CM from these osteocytic cells after FF or HG treatment was also inhibited 
compared to that observed with the CM from the corresponding non-mechanically stimulated 
cells.  
Inhibition of cell proliferation and arrest of cell cycle progression are required for 
osteoclast differentiation. RANKL has been reported to suppress proliferation of osteoclastic 
cells (Bharti et al., 2004) through induction of the cyclin-dependent kinase inhibitors p27KIP1 
and p21CIP1 (Sankar et al., 2004). According to this notion, we found that exposure of RAW 
264.7 cells to the MLO-Y4-cell CM inhibited their proliferation but allowed osteoclast-like cell 
formation, while the opposite occurred after exposure to the CM of FF-stimulated cells 
independently of the presence of HG. Consistently, this mechanical stimulation reduced the 
production of RANKL by these osteocytic cells, as shown here and previously by other 
investigators (Kim et al., 2006; Lau et al., 2010). In this sense, we also found that IL-6 secretion 
was inhibited by FF. This cytokine has been shown to promote bone resorption mainly by its 
ability to increase RANKL production in osteoblastic lineage cells (Palmqvist et al., 2002; 
Tamura et al., 1993). Moreover, IL-6 is able to stimulate osteoclast formation in vitro, and IL-6 
receptors have been identified in mature osteoclasts (Gao et al., 1998; Tamura et al., 1993). 
Furthermore, it isknown that mechanical stimulation of osteocytes induces the production of 
other factors that caninhibit osteoclast differentiation, such as nitric oxide or the 
phosphoglycoprotein MEPE (Kulkarni et al., 2010; Tan et al., 2007). Our results also showed 
that FF or HG pre-treatment of MLO-Y4 cells had a different consequence on osteoclast 
function. Thus, in contrast to FF, HG pre-exposure failed to affect either RANKL or IL-6 
secretion and allowed the formation of osteoclast multinucleated giant cells, although they were 
unable to resorb hydroxyapatite. The effect of DM on osteoclastogenesis and osteoclast activity 
in vivo is presently unclear (Bouillon et al., 1995; McCabe, 2007; Tsentidis et al., 2015), but 
osteoclast precursor exposure to HG in vitro has been shown to directly inhibit the expression of 
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two molecules, v-ATPase V0 subunit d2 and dendritic cell-specific transmembrane protein, 
which are key in the process of osteoclast fusion (Wittrant et al., 2008; Xu et al., 2015). 
Collectively, these data suggest that HG might directly and indirectly inhibit osteoclast function, 
affecting the formation of mature osteoclasts from osteoclast progenitors and also osteoclast 
activity by targeting osteocytes.  
The present findings are the first to our knowledge suggesting that HG affects osteocyte 
mechanotransduction to impact osteocyte-osteoclast communication, and open new avenues for 
understanding the mechanisms whereby DM can disturb bone metabolism.
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FIGURE LEGENDS 
 
Fig. 1. HG prevents the pro-survival effect of FF on osteocytic MLO-Y4cells. 
MLO-Y4 cells were exposed to normal glucose (NG), HG or L-glucose (25 mM) -osmotic 
control- for 24h before pulsatile (8 Hz) FF stimulation (10 dynes/cm2) for 10minwas carried out. 
Static control (SC) corresponds to non-mechanically stimulated cells. (A) p-GSK3β, total and 
nuclear β-catenin,and (B) total p-ERK and nuclear ERK protein levels were evaluated by 
Western blotting in cell and nuclear extracts. Representative autoradiograms are shown. The 
dividing lines indicate different parts of the same gel (A).(C)MLO-Y4-nGFP cells were exposed 
to 50 µM etoposide after FF (or under SC) for 6 h, and subsequently apoptosis was assessed by 
enumerating nGFP-positive MLO-Y4 cells exhibiting chromatin condensation, and the 
percentage of apoptotic cells (left panel) or the Δ between percentage of apoptotic cells under 
HG and NG exposure (right panel), were shown. Apoptosis (mean ± SD) represented 3.6 ± 1.3 
%in etoposide-untreated cells. Values correspond to mean ± SD of at least 3 independent 
experiments in duplicate.*p<0.05; **p<0.01 vs NG-SC value; #p<0.01 vs NG-FF value. 
Fig. 2.HG prevents the pro-survival effect of FF on osteoblasticMC3T3-E1 cells. 
MC3T3-E1 cells were exposed to NG, HG (25mM) or L-glucose for 24h before FF stimulation 
(10 dynes/cm2) for 10min, or static control (SC). (A) p-GSK3β, β-catenin, and (B) p-ERK 
protein levels were evaluated by Western blotting in total protein extracts obtained immediately 
after the FF. (C) To evaluate cell death, MC3T3-E1 cells were exposed to 50 µM etoposide 
right after the FF or the SC, for 6 h, and subsequently trypan blue exclusion was determined. 
Values correspond to mean ± SD of 3 independent experiments in duplicate. *p<0.05; **p<0.01 
vs NG SC value; #p<0.01 vs NG FF value.  
Fig. 3.HG or FF pre-treatment inhibited osteoclast precursor migration induced by the CM from 
MLO-Y4cells but not from MC3T3-E1 cells. 
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The conditioned medium (CM) from MLO-Y4 and MC3T3-E1 cells subjected or not (static 
control, SC) to FFfollowing pre-treatment with HG or normal glucose (NG) for 24 h,was 
collected 18 h thereafter, as described in the text. (A, left and B) RAW 264.7 cell migration was 
assessed by exposing these cells to the different CMs [or to growth medium alone (Co)] for 6 h, 
using Costar transwellcell culture chamber inserts (8 μm pore size),or a wound healing assay 
(A, right), as described in the text. Representative images are shown in each case. Values 
correspond to mean ± SD of 3 independent experiments in triplicate. **p<0.01 vsNG-SC-CM 
value. 
Fig. 4. Both HG and FF induce changes in chemokinesecretion by MLO-Y4 cells. 
MLO-Y4 cells were subjected or not (static control, SC) to FF following pre-treatment with HG 
or normal glucose (NG) for 24 h, and the cell-conditioned medium (CM) was collected 18h 
thereafterto determine the following chemokines by Luminex multiplex assay: VEGF, 
RANTES, MIP-1a, MIP-1b, MCP-1 and GM-CSF. Values correspond to mean ± SD of 3 
independent experiments in triplicate. *p<0.05 vs NG-SC value; #p<0.05 vs NG-FF value. 
Fig. 5. HG and FF pre-treatment differentially affect osteoclast precursor proliferation, 
differentiation and activity induced by theMLO-Y4 cell-conditioned medium. 
RAW 264.7 cells were exposed to the MLO-Y4 conditioned medium (CM) [or not (Co)] 
following HG exposure and/or FF stimulation, for 14 d, as described in the text. A) RAW 264.7 
cell viability was determined by propidium iodide exclusion using flow cytometry, and 
(B)proliferation was assayed by flow cytometry as described in the text. Values correspond to 
mean ± SD of 3 independent experiments in triplicate. (C) RAW 264.7 cells were exposed to the 
different MLO-Y4 CMs supplemented with 40 ng/ml of RANKL and 25 ng/ml of M-CSFto 
stimulate osteoclast differentiation for 14 d. Osteoclast differentiation (upper panel) was 
observed by confocal microscopy (giant cells with actin ring and at least 3 nuclei) and osteoclast 
activity as formation of resorption lacunae detected by SEM (lower panel) was assessed by 
culturing RAW264.7 cells on hydroxyapatite disksin different experimental conditions for 14 d. 
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Scale bars = 20µm. (D)size of the resorption cavities in each experimental group was 
represented *p<0.01 vs Co value; **p<0.01 vs Co value.# p<0.01 vs NG-SC; ## p<0.05 NG-
SC.  
Fig. 6. HG and FF differentially affect RANKL and IL-6 secretion in MLO-Y4 cells. 
RANKL (A) and IL-6 (B) in the MLO-Y4-CMwere analyzed by ELISA as described in 
Materials and Methods. Values correspond to mean ± SD of 3 independent experiments in 
triplicate. *p<0.05; **<0.01vs all the other experimental conditionsin each case. 
 






